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Reduction of endoplasmic reticulum
stress inhibits neointima formation after
vascular injury
Shutaro Ishimura1*, Masato Furuhashi1*, Tomohiro Mita1, Takahiro Fuseya1, Yuki Watanabe1,
Kyoko Hoshina1, Nobuaki Kokubu1, Katsumi Inoue2, Hideaki Yoshida1 & Tetsuji Miura1
1Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-
ku, Sapporo 060-8543, Japan, 2Department of Laboratory Medicine, Kokura Memorial Hospital, 3-2-1 Asano, Kokurakita-ku,
Kitakyushu, Kokura 802-8555, Japan.
Endoplasmic reticulum (ER) stress and inappropriate adaptation through the unfolded protein response
(UPR) are predominant features of pathological processes. However, little is known about the link between
ER stress and endovascular injury. We investigated the involvement of ER stress in neointima hyperplasia
after vascular injury. The femoral arteries of 7-8-week-old male mice were subjected to wire-induced
vascular injury. After 4weeks, immunohistological analysis showed that ER stressmarkerswere upregulated
in the hyperplastic neointima. Neointima formation was increased by 54.8% in X-box binding protein-1
(XBP1) heterozygous mice, a model of compromised UPR. Knockdown of Xbp1 in human coronary artery
smooth muscle cells (CASMC) in vitro promoted cell proliferation and migration. Furthermore, treatment
with ER stress reducers, 4-phenylbutyrate (4-PBA) and tauroursodeoxycholic acid (TUDCA), decreased the
intima-to-media ratio after wire injury by 50.0% and 72.8%, respectively. Chronic stimulation of CASMC
with PDGF-BB activated the UPR, and treatment with 4-PBA and TUDCA significantly suppressed the
PDGF-BB-induced ER stress markers in CASMC and the proliferation and migration of CASMC. In
conclusion, increased ER stress contributes to neointima formation after vascular injury, while UPR
signaling downstream of XBP1 plays a suppressive role. Suppression of ER stress would be a novel strategy
against post-angioplasty vascular restenosis.
R
estenosis after percutaneous coronary intervention is still a major obstacle in treatment of coronary artery
disease. Although drug-eluting stents have proven to be more effective than bare metal stents in reducing
the incidence of restenosis after percutaneous coronary intervention (PCI), coronary restenosis and stent
thrombosis still remain as significant problems1–4. Therefore, new approaches to these problems in addition to
traditional methods for prevention of restenosis, such as administration of immunosuppressants or antiplatelet
drugs, are needed. Neointima hyperplasia in coronary lesions subjected to PCI is a pathologic hallmark of
restenosis, and it is widely accepted that vascular injury activates vascular smooth muscle cells in the media
and induces neointima formation by cell migration into intima and proliferation5.
Complex adaptive and maladaptive processes underlie atherosclerosis and response to injury in the coronary
artery. Production of proper amounts of functional proteins and their transport are crucial in the adaptive
response, and the endoplasmic reticulum (ER) is a vital organelle for quality control of proteins and coordinating
the synthesis, folding and trafficking of proteins. Accumulation of unfolded ormisfolded proteins in the ER is one
of the endogenous sources of cellular stress, known as ER stress. ER stress can occur when cells face physiological
processes that demand a high rate of protein synthesis and secretion as well as harmful stresses, including
infection, hypoxia, oxidative stress, exposure to a toxic substance and production of mutated proteins. A com-
pensational reaction to ER stress is called an unfolded protein response (UPR), which has mainly three signaling
pathways by sensor proteins: PKR-like ER kinase (PERK), activating transcription factor 6 (ATF6) and inositol-
requiring enzyme-1a (IRE1a)-X-box binding protein-1 (XBP1) pathways, through the mechanism of arresting
translation to alleviate additional sources of ER stress, induction of chaperones to increase protein folding
capacity and degradation of unfolded or misfolded proteins6.
ER stress and inappropriate adaptation through the UPR are predominant features of pathological processes in
several types of tissues. Recent studies have revealed relationships between ER stress and a wide range of diseases,
including neurodegenerative disease7, cancer8, pulmonary artery hypertension9 and metabolic disorders10.
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However, little is known about the link between ER stress and endo-
vascular injury. We therefore investigated the involvement of ER
stress in neointima hyperplasia after endovascular injury by use of
a model of wire-induced femoral artery injury, which mimics vas-
cular remodeling following coronary angioplasty11.
Results
Involvement of ER stress in neointima formation after vascular
injury.Representative staining of the coronary artery after PCI using
a drug-eluting stent (XienceH; Abbott Vascular, Tokyo, Japan) in an
autopsy case (female; 58 years old) is shown in Figure 1A and 1B.
Neointima formation after angioplasty was prevented by a drug-
eluting stent in a coronary lesion (Figure 1A) but not in another
stenotic lesion in the same patient (Figure 1B), indicating that
restenosis after angioplasty is not totally eradicated by drug-eluting
stents.
Neointima formation in the coronary artery after PCI could be
mimicked in the femoral arteries of mice. The left femoral arteries of
7–8-week-old male mice were subjected to wire-induced vascular
injury. Four weeks later, neointima formation mainly consisting of
vascular smooth muscle cells, which was confirmed by staining of a-
smoothmuscle actin (a-SMA), had developed in the wire-injured left
femoral artery (Figure 1C). In the non-injured right femoral artery,
no neointima formation was observed. Immunohistological analysis
for ER stress markers showed that glucose-regulated protein 94
(GRP94), protein disulfide isomerase (PDI) and phosphorylation
of eukaryotic initiation factor 2 a (eIF2a) (p-eIF2a) and IRE1a
(p-IRE1a) were present in the hyperplastic neointima in injured
regions (Figure 1D).
Effect of Xbp1-haploinsufficiency on neointima formation. To
further investigate the association between vascular remodeling
and ER stress in vivo, wire injury-mediated neointima hyperplasia
was induced in XBP1 heterozygous (Xbp11/2) mice as a model of
compromised UPR. Thickness of the neointima after wire injury was
significantly larger (by 54.8%) in the Xbp11/2 mice than in wild-type
mice (Figure 2A, B).
The mechanism by which XBP1 deletion promoted neointima
formation was investigated by using human coronary artery smooth
muscle cells (CASMC). In CASMC, siRNA-mediated Xbp1-knock-
down resulted in efficient gene suppression of total XBP1 (tXbp1)
and the spliced form of XBP1 (sXbp1) by 81.1% and 83.0%, respect-
ively (Figure 2C). Knockdown of Xbp1 in CASMC significantly
decreased gene expression of PDI and ER degradation-enhancing
a-mannosidase-like protein (EDEM), downstream molecules of
XBP1, whereas gene expression of IRE1a, an upstream molecule of
XBP1, was not significantly changed (Figure 2C). On the other hand,
Xbp1-knockdown in CASMC did not significantly change gene
expression of GRP94 and GRP78, downstream of the ATF6 branch,
or activating transcription factor 4 (ATF4) and CCAAT/enhancer
binding protein homologous protein (CHOP), downstream of the
PERK branch (Figure 2D).
An MTS assay showed that Xbp1-knockdown in CASMC
significantly promoted basal and platelet-derived growth factor
(PDGF)-BB-induced cell proliferation compared with the controls
Figure 1 | Histological analysis of neointima formation. (A), (B). H-E staining of the coronary artery in an autopsy case (female; 58 years old) of a
diabetic patient with angina pectoris who previously had percutaneous coronary intervention (PCI) using a drug-eluting stent, XienceH (Abbott Vascular
Japan, Tokyo). Representative images of the coronary artery in the absence (A) and presence (B) of neointima formation after stenting are shown. Strut
thickness: 81 mm. (C). Left femoral arteries of 7-8-week-oldmalemice were subjected to wire-induced vascular injury. After 4 weeks, Elastica-VanGieson
(EVG) staining was performed in both the non-injured right and injured left femoral arteries, and histological staining was performed using a-SMA
antibody in the wire-injured left femoral artery. (D). Histological staining was performed using antibodies of GRP94, PDI, phospho-eIF2a (p-eIF2a) and
phospho-IRE1a (p-IRE1a) in the wire-injured left femoral artery. Scale bars: 50 mm.
www.nature.com/scientificreports
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Figure 2 | Neointima formation, cell proliferation, cell migration and inflammation in Xbp1 haploinsufficiency. (A), (B). Left femoral arteries of 7-8-week-
old male Xbp11/1 (n 5 7) and Xbp11/- (n 5 7) mice were subjected to wire-induced vascular injury. After 4 weeks, EVG staining was performed in the left
femoral artery (A). Scale bars: 50 mm. The extent of neointima formation was evaluated as intima-to-media ratio in the wire-injured artery of Xbp11/1 and
Xbp11/2 mice (B). *P, 0.05. (C), (D). Gene expression of unfolded protein response (UPR) markers in the IRE1a-XBP1 branch (C) and the other branches
(D) in Xbp1-knockdown human coronary artery smooth muscle cells (CASMC). *P , 0.05. (E). Cell proliferation was assessed by an MTS assay in Xbp1-
knockdown CASMC with 20 ng/ml platelet-derived growth factor-BB (PDGF-BB) for 48 h. *P , 0.05 vs. Control-PDGF-BB(-); {P , 0.05 vs. Xbp1 KD-
PDGF-BB(-); {P, 0.05 vs. Control-PDGF-BB(1). (F). Cell migration was assessed by a scratch wound assay in Xbp1-knockdown CASMC treated with 20 ng/
ml PDGF-BB for 8 h. Photographs were taken, andmigration distance wasmeasured by ImageJ. *P, 0.05. (G). Gene expression of PDGF receptors, PDGFR-a
and PDGFR-b, in Xbp1-knockdown CASMC. *P, 0.05. (H). Western blotting analysis of ER stress markers in Xbp1-knockdown CASMC treated with 20 ng/
ml PDGF-BB for 48 h. (I). Gene expression of inflammatory markers, IL-1b and IL-6, in Xbp1-knockdown CASMC treated with 20 ng/ml PDGF-BB for 48 h.
*P , 0.05 vs. Control-PDGF-BB(2); {P , 0.05 vs. Xbp1 KD-PDGF-BB(2); {P , 0.05 vs. Control-PDGF-BB(1).
www.nature.com/scientificreports
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(Figure 2E). A scratch wound assay showed that PDGF-BB-induced
cell migration was significantly increased in Xbp1-knockdown
CASMC compared with that in control cells (Figure 2F). Gene
expression levels of PDGF receptor-a (PDGFR-a) and PDGF recep-
tor-b (PDGFR-b) were significantly higher in Xbp1-knockdown
CASMC than in the controls (Figure 2G). In addition, knockdown
of Xbp1 significantly increased phosphorylation of IRE1a upstream
of XBP1 but not GRP94 or GRP78 downstream of the ATF6 branch
upon chronic stimulation with PDGF-BB at the dose of 20 ng/ml for
48 h (Figure 2H). Furthermore, knockdown of Xbp1 significantly
increased gene expression levels of inflammatory cytokines, includ-
ing interleukin-1b (IL-1b) and interleukin-6 (IL-6), in a basal con-
dition and further increased those gene expression levels upon
chronic stimulation with PDGF-BB in CASMC (Figure 2I).
Effect of ER stress reducers on neointima formation. Treatment
with ER stress reducers known as chemical chaperones, 4-phenylbutyric
acid (4-PBA) and tauroursodeoxycholic acid (TUDCA), for 4 weeks did
not affect media thickness but significantly decreased intima thickness,
resulting in a reduction in the intima-to-media ratio, a severity index of
neointima formation, by 50.0% and 72.8%, respectively, compared with
those after vehicle treatment (Figure 3A, B).
Significant proliferation of CASMC by treatment with 20–80 ng/
ml PDGF-BB for 48 h (Figure S1) and absence of toxicity of treat-
ment with 4-PBA (Figure S2A) or TUDCA (Figure S2B) at the dose
of up to 0.5 mM for 48 h in CASMC were confirmed in an MTS
assay. Proliferation of CASMC was induced by chronic stimulation
with 20 ng/ml PDGF-BB for 48 h, and treatment with 0.5 mM 4-
PBA (Figure 3C) or 0.5 mMTUDCA (Figure 3D) significantly inhib-
ited PDGF-BB-induced cell proliferation. A scratch wound assay
showed that both 0.5 mM 4-PBA and 0.5 mM TUDCA significantly
suppressed cell migration after stimulation with 20 ng/ml PDGF-BB
for 5 h (Figure 3E, F) as well as serum stimulation for 5 h (Figure
S3A, B).
Effect of ER stress reducers onUPR and inflammation in CASMC.
Chronic stimulation of CASMC with 20 ng/ml PDGF-BB for 48 h
led to phosphorylation of extracellular signal-regulated kinase (ERK)
and activation of the UPR as indicated by phosphorylation of IRE1a
and eIF2a and induction of GRP94 andGRP78 (Figure 4A, B) as well
as elevation of mRNA levels of Ire1a, sXbp1 and Pdi in the IRE1a-
XBP1 branch, Grp94 and Grp78 in the ATF6 branch, and Perk, Atf4
and Chop in the PERK branch (Figure 4C, D).
Similarly, but weakly, chronic stimulation of CASMC with 20 ng/
ml PDGF-AA for 48 h induced gene expression of ER stress markers
and activation of ERK and the UPR (Figure S4A, B). Treatment with
0.5 mM 4-PBA or 0.5 mMTUDCA significantly suppressed PDGF-
BB-induced elevation of protein and mRNA levels of ER stress mar-
kers in CASMC (Figure 4A–D). Moreover, chronic stimulation of
CASMC with PDGF-BB (Figure 4E, F) or PDGF-AA (Figure S4C)
significantly increased expression levels of inflammatory genes,
including Il1b and Il6, and the PDGF-BB-induced inflammatory
genes were reduced by treatment with 4-PBA (Figure 4E) or
TUDCA (Figure 4F). Chronic treatment of CASMC with PDGF-
BB (Figure 4G, H) or PDGF-AA (Figure S4D) for 48 h significantly
increased gene expression of Pdgfra and conversely down-regulated
gene expression of Pdgfrb. Treatment with TUDCA, but not PBA,
decreased gene expression levels of PDGF receptors (Figure 4G, H).
Discussion
We demonstrated for the first time that activation of all branches of
the UPR, including IRE1a-XBP1, ATF6 and PERK pathways, and
accompanying inflammation are associated with neointima forma-
tion in the artery after wire injury. Neointima thickening was aug-
mented in Xbp11/2 mice, and proliferative and migratory responses
of CASMC to PDGF-BB in vitro were enhanced by knockdown of
Xbp1. The augmented proliferation of CASMC by knockdown of
Xbp1 was associated with enhanced signaling (phosphorylation) of
IRE1a, a molecule upstream of XBP1, as well as induction of inflam-
mation. In contrast, overall suppression of UPRs by use of 4-PBA or
TUDCA suppressed neointima hyperplasia after wire injury in vivo
and proliferation andmigration of CASMAC in vitro. These findings
suggest that ER stress contributes to vascular remodeling following
intravascular injury, while UPR signaling downstream of XBP1 plays
a suppressive role in neointima formation.
The pathology of neointima formation is traditionally thought to
be migration and proliferation in the media, which are affected by
various elements derived from around immune and vascular cells,
such as growth factors and inflammatory cytokines5. Recent studies
have also shown that smooth muscle cell-like cells differentiated
from bone marrow-derived progenitor cells play important roles in
neointima formation12,13. PDGFs have a prominent role in themigra-
tion of smoothmuscle cells into the neointima following acute injury
and atherosclerosis14. PDGF-BB can bind to both the PDGFR-a and
PDGFR-b, whereas PDGF-AA can only bind to the PDGFR-a14,
suggesting there might be different in the significance of neointima
formation. UPR activation and increased gene expression of inflam-
matory genes in CASMC were similar between chronic stimulation
of PDGF-BB and PDGF-AA, but the effect seemed to be stronger in
the treatment with PDGF-BB than PDGF-AA (Figure 4, S4). Since it
has been reported that activation of PDGF-BB is involved in neoin-
tima formation after endovascular injury14,15, we mainly examined
roles of ER stress in responses of proliferation and migration func-
tions in CASMC to PDGF-BB in the present study. PDGF-BB-
induced proliferation of CASMC and enhanced migratory function
were accompanied by upregulation of UPRmarkers. These effects of
PDGF-BB on CASMC were significantly suppressed by 4-PBA or
TUDCA, indicating that ER stress was causally related to prolifera-
tion/migration of CASMC.
It has been shown that activation of UPR itself induces inflam-
mation through c-Jun N-terminal kinase (JNK)-activator protein-1
(AP-1) and inhibitor of k B (IkB) kinase (IKK)-nuclear factor-k B
(NF-kB) pathways16–18: IRE1a phosphorylates JNK and IKK,
whereas the PERK-eIF2a pathway attenuates IkB, resulting in NF-
kB activation. Activation of NF-kB has been reported to promote
vascular smooth muscle cell proliferation and neointima forma-
tion19–22. Therefore, prolonged UPR activation under the condition
of proliferation of vascular smoothmuscle cells would cause vascular
inflammation, leading to the development and acceleration of neoin-
tima formation. Moreover, it is well known that chronic inflam-
mation per se induces ER stress23. Thus, a vicious cycle of
prolonged UPR and chronic inflammation might underlie persistent
proliferation of smooth muscle cells and neointima formation after
wire injury. This notion is supported by the finding that expression
levels of inflammatory cytokines, including IL-1b and IL-6, were
increased with activation of UPR upon chronic stimulation with
PDGF-BB (Figures 2, 4).
Reduction of XBP1 expression enhanced neointima hyperplasia
after wire injury in vivo (Figure 2A, B) and proliferation/migration of
CASMC in response to PDGF-BB in vitro (Figure 2E, F). The altered
responses of smoothmuscle cells by partial deletion ofXbp1might be
attributable to reduced PDI- and EDEM-mediated signals down-
stream of XBP1 and/or enhanced IRE1a-JNK- and IRE1a-IKK-
mediated activation of inflammation by a feedback signal to
upstream of XBP1. In fact, we showed augmentation of IRE1a activa-
tion and gene induction of inflammatory cytokines by knockdown of
Xbp1 in CASMC (Figure 2h, I).
Interestingly, expression levels of PDGF receptors, PDGFR-a and
PDGFR-b, were increased in Xbp1-knockdown CASMC compared
with the levels in control cells (Figure 2G). Furthermore, chronic
treatment of CASMC with PDGF-BB significantly increased gene
expression of PDGFR-a, though gene expression of PDGFR-b was
www.nature.com/scientificreports
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down-regulated by ligands (Figure 4G, 4H, S4D). Increased expression
levels of PDGF and its receptors, PDGFR-a and PDGFR-b, in athero-
sclerotic lesions compared with those in the normal vessel wall have
been reported14. An important role of PDGFR-b in arterial injury
disorders and potential benefit of its modulation for preventing hyper-
plasia of arterial smooth muscle cells have been shown24,25. Recent
studies have also demonstrated that PDGFR-a promoted proliferation
of vascular smooth muscle cells26–28. Although there has been no
report regarding the association between PDGFRs and UPR, express-
ion of PDGFR-a has been shown to be upregualted by IL-1b via
augmentation of CCAAT/enhancer binding protein d (C/EBPd)
expression29,30. In the present study, knockdown of Xbp1 increased
the expression of IL-1b as well as PDGF receptors. In previous studies,
expression of C/EBPd was enhanced in IRE1a-null mice and Ire1a-
knockdown hepatocytes31, and ER stress increased the production of
IL-1b in pancreatic b cells and THP-1 cells through IRE1a and PERK
pathways32. Collectively, these findings support the notion that C/
EBPd-mediated increase in PDGFR-a expression by IL-1b is involved
in smooth muscle cell hyperplasia by partial deletion of XBP1.
In the present study, we revealed beneficial effects of chemical
chaperones, 4-PBA and TUDCA, on both wire injury-induced
neointima formation in the artery in vivo and on proliferation,
migration and inflammatory response of CASMC in vitro.
Chemical chaperones are thought to reduce ER stress through sta-
bilizing misfolded proteins, reducing their aggregation, facilitating
escape ofmutant proteins from the cell’s control systems and altering
the activity of endogenous molecular chaperones. Both 4-PBA and
TUDCA have pharmacological actions other than those as chemical
chaperones, such as inhibition of histone deacetylase by 4-PBA and
stabilization of the mitochondrial membrane by TUDCA33.
However, our observations that two structurally different chemical
chaperones had similar impacts on smoothmuscle cells in vivo and in
vitro except for gene expression of PDGF receptors strongly indicate
that suppression of ER stress was a mechanism of their actions on
neointima formation after vascular injury.
In conclusion, activation of all branches of the UPR, including
IRE1a-XBP1, ATF6 and PERK pathways, is associated with neoin-
tima formation after vascular injury and with PDGF-BB-induced
proliferation, migration and inflammation in vascular smooth mus-
cle cells. The responses of smooth muscle cells to wire injury in vivo
and to PDGF-BB in vitrowere augmented by partial deletion of XBP1
but were significantly attenuated by chemical chaperones. The
Figure 3 | Effects of chemical chaperones on neointima formation, cell proliferation and cell migration. (A), (B). Representative staining of EVG in the
wired-injured left femoral arteries of mice treated with daily intraperitoneal injection of a vehicle (n 5 11), 100 mg/kg 4-PBA (n 5 8) or 500 mg/kg
TUDCA (n5 6) for 4weeks (A). Scale bars: 50 mm.The extent of neointima formationwas evaluated as intima-to-media ratio in the wire-injured femoral
artery (B). *P, 0.05 vs. Vehicle. (C), (D). Cell proliferation was assessed by an MTS assay in chronic stimulation with 20 ng/ml PDGF-BB for 48 h in
CASMC treated with 0-0.5 mM of 4-PBA (C) or 0–0.5 mM of TUDCA (D). *P , 0.05 vs. PDGF-BB(2); {P , 0.05 vs. PDGF-BB(1). (E), (F). Cell
migration was assessed by a scratch wound assay in CASMC treated with 0.5 mM4-PBA (E) or 0.5 mMTUDCA (F) upon stimulation with PDGF-BB for
5 h. Photographs were taken, and migration distance was measured by ImageJ. *P , 0.05.
www.nature.com/scientificreports
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results suggest that the use of a chemical chaperone is beneficial for
prevention of post-angioplasty vascular restenosis, though UPR sig-
naling downstream of XBP1 plays some suppressive role in neoin-
tima formation.
Methods
Coronary artery specimens. A set of coronary artery specimens of an autopsy case
was obtained in accordance with the Institutional Review Board of the Kokura
Memorial Hospital and Sapporo Medical University. Written informed consent was
received from bereaved family members.
Biochemical reagents and animals.All experimental protocols were approved by the
Animal Care Committee of Sapporo Medical University, and animal care and
experimental procedures performed in accordance with the Animal Care Committee
of SapporoMedical University. All biochemical reagents were purchased from Sigma-
Aldrich (Saint Louis, MO) unless indicated otherwise. Male C57BL/6J mice were
obtained from Oriental Yeast (Tokyo, Japan). XBP1 heterozygous (Xbp11/2) mice
were generated in the laboratory of Dr. Laurie H. Glimcher (Weill Cornell Medical
College). They were backcrossed for more than 8 generations into the C56BL/6J
genetic background. Mice were kept on a 12-hour light cycle in a pathogen-free
barrier facility and were placed on a regular chow, ad libitum.
Wire injury model. Male mice aged 7–8 weeks were anesthetized with an
intraperitoneal injection of pentobarbital (50 mg/kg), and endoluminal injury of the
left femoral artery was performed as previously described11. In brief, the left femoral
artery was exposed and clamped upstream and downstream of the artery. From the
branch of the femoral artery, a wire (diameter: 0.014 inches) was inserted into the
artery and removed from the vessel followed by branch ligation. Treatment with
intraperitoneal injection of 100 mg/kg 4-PBA (Alpha Aesar, Heysham, UK), 500 mg/
kg TUDCA (Tokyo Chemical Industry, Tokyo, Japan) or a vehicle was performed
once a day for 4 weeks.
Histological analysis. At 4 weeks after wire injury, mice were anesthetized and fixed
by perfusion with saline followed by 10% formalin through a cannula placed in the left
ventricle. Both femoral arteries were excised from each mouse and embedded in
paraffin. Neointima formation in the femoral arteries was evaluated at ten locations at
100-mm intervals, with the most distal site located at the origin of the branch through
which the wire had been inserted. The sections were stained by the Elastica-Van
Gieson (EVG) protocol. Images of arteries were captured with a digital color camera
Figure 4 | Effects of chemical chaperones onPDGF-BB-inducedUPRactivation and inflammation inCASMC. (A), (B).Western blotting analysis of ER
stress markers in CASMC treated with 0.5 mM 4-PBA (A) and 0.5 mM TUDCA (B) upon chronic stimulation with 20 ng/ml PDGF-BB for 48 h.
(C–H). Gene expression analysis of ER stress markers (C, D), inflammatory cytokines (E, F) and PDGF receptors (G, H) in CASMC treated with 0.5 mM
4-PBA and 0.5 mM TUDCA, respectively, upon chronic stimulation with 20 ng/ml PDGF-BB for 48 h. *P, 0.05 vs. Vehicle, {P, 0.05 vs. PDGF-BB.
www.nature.com/scientificreports
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(DP21; Olympus, Tokyo, Japan) mounted on a microscope (CX41; Olympus).
Quantitative analysis for areas of the intima and media was performed using ImageJ
software. All of the measurements were performed in a double-blind manner by two
different researchers. For immunohistochemical analysis, sections were incubated
overnight at 4uC with primary antibodies against a-SMA (Dako, High Wycombe,
UK), GRP94 (Enzo Life Science, Farmingdale, NY), PDI (Cell Signaling, Danvers,
MA), phospho-eIF2a (Invitrogen, Carlsbad, CA) and phospho-IRE1a (Novus
Biologicals, Littleton, CO). The sections were treated with rabbit biotinylated
antibodies against rat IgG for 1 h at room temperature followed by incubation with
avidin-biotin complex (Vectastain Elite ABC; Vector Laboratories, Burlingame, CA)
and visualized with ImmPACTDAB peroxidase substrate. Slides were counterstained
with hematoxylin.
Cell culture.Human coronary artery smooth muscle cells (CASMC) were purchased
from Lonza Inc. (Walkersville, MD) and were grown in a smooth muscle growth
medium (SmGM; Lonza) including smooth muscle basal medium (SmBM) with 5%
fetal bovine serum (FBS) according to the manufacturer’s instructions. After serum
starvation for 24 h, CASMC were stimulated with SmBM containing 0–80 ng/ml
PDGF-BB or 20 ng/ml PDGF-AA (R&D, Minneapolis, MN) in the presence of 0–
0.5 mM 4-PBA or 0–0.5 mM TUDCA for 48 h.
Small interfering RNA knockdown. Small interfering RNA (siRNA) analysis was
performed by using Stealth RNAi (Invitrogen) targeting Xbp1 mRNA (Cat.
#10620319, AAG GGC AUU UGA AGA ACA UGA CUG G) and negative control
(Cat. #12935-200). CASMCwere transfected with specific or control Stealth RNAi by
lipofectamine 2000 (Invitrogen) and cultured for 24 h.
Cell proliferation andmigration assays.AnMTS assay was performed for assessing
cell proliferation using the cell titer Aqueous One Solution Proliferation Assay
(Promega, Madison, WI). After serum starvation for 24 h, CASMC were stimulated
with SmBM containing 20 ng/ml PDGF-BB in the presence of 0–0.5 mM 4-PBA or
0–0.5 mM TUDCA for 48 h. A scratch wound assay was performed for determining
cell migration. After overnight serum starvation, CASMC were scratched with a
sterile pipette tip to produce a straight cell-free zone. Cells were stimulated with
20 ng/ml PDGF-BB or 5% serum in the presence and absence of 0.5 mM 4-PBA or
0.5 mM TUDCA. Pictures were taken at baseline and after stimulation with PDGF-
BB for 5–8 h or serum for 5 h. Migration distance was measured using ImageJ
software.
Quantitative real-time PCR. Total RNA was isolated using Trizol Reagent
(Invitrogen). One mg of total RNAwas reverse-transcribed by using the high capacity
cDNA archive kit (Applied Biosystems, Foster City, CA). Quantitative real-time PCR
analysis was performed using SYBR Green in the real-time PCR system (Applied
Biosystems, Warrington, UK). The thermal cycling program was 10 min at 95uC for
enzyme activation and 40 cycles of denaturation for 15 s at 95uC, 30-s annealing at
58uC and 30-s extension at 72uC. Primers used in the present study are listed in Table
S1. To normalize expression data, 18s rRNA was used as an internal control gene.
Western blotting. Total protein content of the samples was assessed by a microplate
protein assay (Bio-Rad, Hercules, CA), and equal amounts of protein per sample and
known molecular weight markers were subjected to SDS–polyacrylamide gel
electrophoresis (SDS-PAGE). Proteins were electrophoretically transferred onto
PVDF membranes (Whatman, Florham Park, NJ) and incubated for 1 h at room
temperature with a blocking solution (3% bovine serum albumin) in Tris-buffered
saline buffer containing 0.1% Tween 20 (TBST). The blocked membranes were
incubated with primary antibodies for ERK, phospho-ERK, IRE1a and PDI (Cell
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